Glimify-M1 Tablet
Manufacturer
Fidus Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Key Information
Short Description
Glimify-M1 Tablet is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels.
Dosage Form
Tablet
Introduction
Glimify-M1 Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. The medicine works by increasing insulin release and lowering glucose production in the liver. It is important to monitor blood sugar levels regularly while taking this medicine. Potential side effects include hypoglycemia and lactic acidosis. Consult your doctor for more information.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimify-M1 Tablet is to be taken with food.
How it works
Glimify-M1 Tablet is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines, and increasing the body's sensitivity to insulin.
Quick Tips
You have been prescribed this combination medicine as it can control blood sugar better than metformin alone. You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Glimify-M1 Tablet. Take it with food to lower your chance of having an upset stomach. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing, persistent nausea, vomiting, and stomach pain as Glimify-M1 Tablet may cause a rare but serious condition called lactic acidosis. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Glimfirst M1 Tablet
Metffil G1 Tablet
Glimwel M 1mg/500mg Tablet
D Pride M 1mg/500mg Tablet
Glimkap M 1 Tablet
Glinate M 1mg/500mg Tablet
Sefmet G 1mg/500mg Tablet
Glimtin M 1mg/500mg Tablet
Glycilead M 1mg/500mg Tablet
Impride-M 1 Tablet
Frequently asked questions
What are the recommended storage conditions for Glimify-M1 Tablet?
Keep this medicine in the container or pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children, and other people.
Can the use of Glimify-M1 Tablet lead to lactic acidosis?
Yes, the use of Glimify-M1 Tablet can lead to lactic acidosis. It is a medical emergency that occurs due to an increase in lactic acid in the blood. This condition is also known as MALA (Metformin-associated lactic acidosis). While rare, it can be dangerous for individuals with pre-existing kidney issues, the elderly, or those who consume significant amounts of alcohol. Symptoms of lactic acidosis may include muscle pain or weakness, dizziness, tiredness, feelings of coldness in arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or a slow heart rate. If experiencing these symptoms, discontinue use of Glimify-M1 Tablet immediately and seek medical attention promptly.
What is Glimify-M1 Tablet?
Glimify-M1 Tablet is a combination medication containing two components: Glimepiride and Metformin. This medication is used to treat type 2 diabetes mellitus (DM). It works by improving blood glucose levels in adults when taken alongside proper diet and regular exercise. Glimepiride increases insulin release from the pancreas, while Metformin lowers glucose production in the liver and enhances insulin sensitivity. However, this combination is not suitable for treating type 1 diabetes.
What are the possible side effects of Glimify-M1 Tablet?
Glimify-M1 Tablet can lead to common side effects like hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, and headache. However, it can also cause serious but rare side effects such as lactic acidosis. Long-term use may also increase the risk of vitamin B12 deficiency.
Can the use of Glimify-M1 Tablet lead to Vitamin B12 deficiency?
Yes, long-term use of Glimify-M1 Tablet can cause a decrease in vitamin B12 levels. It inhibits the absorption of vitamin B12 in the stomach. Prolonged deficiency can lead to anemia, nerve problems such as tingling and numbness in hands and feet, weakness, urinary issues, changes in mental status, difficulty maintaining balance (ataxia). To mitigate these risks, it is recommended to obtain vitamin B12 from external sources at least once a year.
Can the use of Glimify-M1 Tablet cause hypoglycemia?
Yes, the use of Glimify-M1 Tablet can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, a rapid heartbeat, and feelings of anxiety or shakiness. This is more likely when missing meals, drinking alcohol, overexerting oneself, or taking other diabetes medications alongside Glimify-M1. Regular blood sugar monitoring is crucial to manage this condition. Always keep glucose tablets, honey, or fruit juice readily available.
Is it safe to take alcohol while I am also taking Glimify-M1 Tablet?
No, it is not safe to consume alcohol alongside Glimify-M1. Alcohol may lower blood sugar levels and increase the risk of hypoglycemia. Additionally, it can contribute to a higher likelihood of lactic acidosis.
